Simultaneous quantitative analysis of N3-ethyladenine and N7-ethylguanine in human leukocyte deoxyribonucleic acid by stable isotope dilution capillary liquid chromatography-nanospray ionization tandem mass spectrometry

Journal of Chromatography A

Volumn 1271, Issue 1, 2013, Pages 86-94

  Chen, Hauh Jyun Candy ^a   Liu, Yen Fu ^a  

^a NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

Capillary LC NSI MS MS; DNA adduct; Ethyladenine; Ethylguanine; Leukocyte; Smoking

Indexed keywords

DNA; IONIZATION OF LIQUIDS; ISOTOPES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEOTIDES; TOBACCO;

CAPILLARY LC-NSI/MS/MS; DNA ADDUCTS; ETHYLADENINE; ETHYLGUANINE; LEUKOCYTE; SMOKING;

NUCLEIC ACIDS;

7 METHYLGUANINE; ADENINE; DNA; ISOTOPE; N 3 ETHYLADENINE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BIOSYNTHESIS; CAPILLARY LIQUID CHROMATOGRAPHY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DILUTION; DNA ADDUCT; HUMAN; HUMAN CELL; ISOTOPE ANALYSIS; LEUKOCYTE; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MEDICAL PROCEDURES; NANOSPRAY IONIZATION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; REACTION TIME; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

EID: 84871372214     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2012.11.033     Document Type: Article

References (43)

1. International Agency for Research on Cancer, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, Lyon, France, 2004, pp. 53-119.
2. Hecht S.S. J. Natl. Cancer Inst. 1999, 91:1194-1210.
3. Thompson C.L., McCoy Z., Lambert J.M., Andries M.J., Lucier G.W. Cancer Res. 1989, 49:6503-6511.
4. Hecht S.S. Mutat. Res. 1999, 424:127-142.
5. Chen H.-J.C., Lin W.-P. Anal. Chem. 2009, 81:9812-9818.
6. Chen H.-J.C., Lin W.-P. Anal. Chem. 2011, 83:8543-8551.
7. Chen H.-J.C. Mol. Nutr. Food Res. 2011, 55:1391-1400.
8. Godschalk R., Nair J., Schooten F.J., Risch A., Drings P., Kayser K., Dienemann H., Bartsch H. Carcinogenesis 2002, 23:2081-2086.
9. Godschalk R., Nair J., Kliem H.C., Wiessler M., Bouvier G., Bartsch H. Chem. Res. Toxicol. 2002, 15:433-437.
10. Prevost V., Shuker D.E.G., Friesen M.D., Eberle G., Rajewsky M.F., Bartsch H. Carcinogenesis 1993, 14:199-204.
11. Kopplin A., Eberle-Adamkiewicz G., Glusenkmo K.H., Nehls P., Kirstein U. Carcinogenesis 1995, 16:2637-2641.
12. Prevost V., Shuker D.E.G. Chem. Res. Toxicol. 1996, 9:439-444.
13. Chao M.-R., Wang C.-J., Chang L.W., Hu C.-W. Carcinogenesis 2006, 27:146-151.
14. Chen H.-J.C., Wang Y.-C., Lin W.-P. Anal. Chem. 2012, 84:2521-2527.
15. Carmella S.G., Chen M., Villalta P.W., Gurney J.G., Hatsukami D.K., Hecht S.S. Carcinogenesis 2002, 23:1903-1910.
16. Hoffmann D., Hoffmann I., El Bayoumy K. Chem. Res. Toxicol. 2001, 14:767-790.
17. Singh R., Kaur B., Farmer P.B. Chem. Res. Toxicol. 2005, 18:249-256.
18. Swann P.F. Mutat. Res. 1990, 233:81-94.
19. Singh R., Sweetman G.M.A., Farmer P.B., Shuker D.E.G., Rich K.J. Chem. Res. Toxicol. 1997, 10:70-77.
20. Chen L., Wang M., Villalta P.W., Hecht S.S. Chem. Res. Toxicol. 2007, 20:1498-1502.
21. Swenberg J.A., Dyroff M.C., Bedell M.A., Popp J.A., Huh N., Kirstein U., Rajewsky M.F. Proc. Natl. Acad. Sci. U.S.A. 1984, 81:1692-1695.
22. Scherer E., Timmer A.P., Emmelot P. Cancer Lett. 1980, 10:1-6.
23. Den Engelse L., De Graaf A., De Brij R.J., Menkveld G.J. Carcinogenesis 1987, 8:751-757.
24. Thomale J., Huh N.H., Nehls P., Eberle G., Rajewsky M.F. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:9883-9887.
25. Bronstein S.M., Skopek T.R., Swenberg J.A. Cancer Res. 1992, 52:2008-2011.
26. Engelberg J., Thomale J., Galhoff A., Rajewsky M.F. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:1635-1640.
27. Singer B. J. Natl. Cancer Inst. 1979, 62:1329-1339.
28. Shuker D.E.G., Farmer P.B. Chem. Res. Toxicol. 1992, 5:450-460.
29. Gates K.S., Nooner T., Dutta S. Chem. Res. Toxicol. 2004, 17:839-856.
30. Vineis P., Perera F. Int. J. Cancer 2000, 88:325-328.
31. Feng S., Roethig H.J., Liang Q., Kinser R., Jin Y., Scherer G., Urban M., Engl J., Riedel K. Biomarkers 2006, 11:28-52.
32. van Delft J.H., van Winden M.J., van den Ende A.M., Baan R.A. Environ. Health Perspect. 1993, 99:25-32.
33. De Groot A.J.L., Jansen J.G., Van Valkenburg C.F.M., Van Zeeland A.A. Mutat. Res. 1994, 307:61-66.
34. Chao M.R., Wang C.J., Yen C.C., Yang H.H., Lu Y.C., Chang L.W., Hu C.W. Biochem. J. 2007, 402:483-490.
35. Balbo S., Villalta P.W., Hecht S.S. Chem. Res. Toxicol. 2011, 24:1729-1734.
36. Singh R., Farmer P.B. Carcinogenesis 2006, 27:178-196.
37. Ciccimaro E., Blair I.A. Bioanalysis 2010, 2:311-341.
38. Bodell W.J., Singer B., Thomas G.H., Cleaver J.E. Nucleic Acids Res. 1979, 6:2819-2829.
39. International Agency for Research on Cancer Monograph on the Evaluation of Carcinogenic Risk of Chemicals to Man, vol. 1 1972, International Agency for Research on Cancer, Lyon, France.
40. Singer B. In vivo formation and persistence of modified nucleosides resulting from alkylating agents. Environ. Health Perspect. 1985, 62:41-48.
41. Mattson M.E., Pollack E.S., Cullen J.W. Am. J. Public. Health 1987, 77:425-431.
42. Speina E., Zielinska M., Barbin A., Gackowski D., Kowalewski J., Graziewicz M.A., Siedlecki J.A., Olinski R., Tudek B. Cancer Res. 2003, 63:4351-4357.
43. Gackowski D., Speina E., Zielinska M., Kowalewski J., Rozalski R., Siomek A., Paciorek T., Tudek B., Olinski R. Cancer Res. 2003, 63:4899-4902.